Anita Roach, Research Program Manager, reports on new lupus therapies and environmental aspects of lupus from American College of Rheumatology's Annual Scientific Meeting last week in San Francisco.
Fans may be surprised she mentions that she has received chemotherapy for her lupus.
An October 2015 update from Health Educator Sarah Stothers, RN, BS, for options on how to make medications like hydroxychloroquine more affordable.
Off-label drugs for the treatment of lupus symptoms represents the standard of care for people with lupus, but current regulations make it difficult for doctors and manufacturers to communicate. Read Sandra C. Raymond's remarks now.
When the Lupus Foundation of America became aware of a hydroxychloroquine (Plaquenil®) shortage, we set out to discover the root of problem. While we still have limited information, we want to alert our constituents to the facts of the situation.
Today’s sessions will focus on pediatric lupus and biomarkers, including a Foundation-funded research program about pediatric lupus in South Africa. Learn more!
In her Expert Column, Dr. Joan T. Merrill, Medical Director, explains why antimalarial medicines are now used to treat lupus.